scholarly journals Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study)

2017 ◽  
Vol 18 (10) ◽  
pp. 2057 ◽  
Author(s):  
Nicholas Obermüller ◽  
Alexander Rosenkranz ◽  
Hans-Walter Müller ◽  
Dennis Hidde ◽  
András Veres ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Clinical Practice ◽  
Kidney Disease ◽  
Term Therapy ◽  
Therapy Outcomes ◽  
Long Term Therapy

scholarly journals Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietin

2005 ◽  
Vol 68 (1) ◽  
pp. 246-255 ◽  
Author(s):  
Eleni C. Papavasiliou ◽  
Chariklia Gouva ◽  
Kostas C. Siamopoulos ◽  
Alexandros D. Tselepis
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Term Therapy ◽  
Paf Acetylhydrolase ◽  
Disease Effect ◽  
Long Term Therapy

Development of chronic kidney disease in essential hypertension during long-term therapy

2004 ◽  
Vol 13 (5) ◽  
pp. 495-500
Author(s):  
Juli??n Segura ◽  
Carlos Campo ◽  
Jos?? A Garc??a-Donaire ◽  
Luis M Ruilope
Keyword(s):  
Chronic Kidney Disease ◽  
Essential Hypertension ◽  
Kidney Disease ◽  
Term Therapy ◽  
Long Term Therapy

scholarly journals PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin

2006 ◽  
Vol 21 (5) ◽  
pp. 1270-1277 ◽  
Author(s):  
Eleni C. Papavasiliou ◽  
Chariklia Gouva ◽  
Kostas C. Siamopoulos ◽  
Alexandros D. Tselepis
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Term Therapy ◽  
Paf Acetylhydrolase ◽  
Disease Effect ◽  
Long Term Therapy

scholarly journals Novel approaches to treatment of locally advanced rectal cancer

2020 ◽  
Vol 10 (3-4) ◽  
pp. 73-83
Author(s):  
A. A. Kachmazov ◽  
L. V. Bolotina ◽  
A. L. Kornietskaya ◽  
Yu. B. Karagodina ◽  
I. V. Droshneva ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Locally Advanced ◽  
Neoadjuvant Chemoradiotherapy ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Term Therapy ◽  
Therapy Outcomes ◽  
Practical Guidelines ◽  
Long Term Therapy

Combination of neoadjuvant chemoradiotherapy with subsequent total mesorectum excision and 6-months of adjuvant chemotherapy remains a standard approach to treatment of locally advanced rectal cancer (T3 or T4 and / or N1–3; M0) for more than 15 years, which is reflected in practical guidelines of most leading oncological societies. However, recent data suggests possibilities of more individualized treatment conceptions with a potential of further improvement of long-term therapy outcomes and patient’s quality of life. In this paper we present review of results of clinical trials which investigated new approaches to treatment of locally advanced rectal cancer.

Sign in / Sign up

Export Citation Format

Share Document